These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

539 related items for PubMed ID: 25496439

  • 1. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
    Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J.
    Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
    [Abstract] [Full Text] [Related]

  • 2. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2013 Feb 14; 48(3):393-405. PubMed ID: 23266466
    [Abstract] [Full Text] [Related]

  • 3. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S, Patil K, Bobade N, Yeole P, Gaikwad R.
    J Drug Target; 2010 Apr 14; 18(3):223-34. PubMed ID: 20030503
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Curr Drug Discov Technol; 2019 Apr 14; 16(4):417-425. PubMed ID: 29669501
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity.
    Raj R, Wairkar S, Sridhar V, Gaud R.
    Int J Biol Macromol; 2018 Apr 01; 109():27-35. PubMed ID: 29247729
    [Abstract] [Full Text] [Related]

  • 8. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 9. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
    Md S, Haque S, Fazil M, Kumar M, Baboota S, Sahni JK, Ali J.
    Expert Opin Drug Deliv; 2014 Jun 30; 11(6):827-42. PubMed ID: 24655115
    [Abstract] [Full Text] [Related]

  • 10. Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
    Bari NK, Fazil M, Hassan MQ, Haider MR, Gaba B, Narang JK, Baboota S, Ali J.
    Int J Biol Macromol; 2015 Nov 30; 81():49-59. PubMed ID: 26210037
    [Abstract] [Full Text] [Related]

  • 11. Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress.
    Nabi B, Rehman S, Fazil M, Khan S, Baboota S, Ali J.
    Drug Dev Ind Pharm; 2020 Mar 30; 46(3):471-483. PubMed ID: 32057274
    [Abstract] [Full Text] [Related]

  • 12. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery.
    Trapani A, De Giglio E, Cafagna D, Denora N, Agrimi G, Cassano T, Gaetani S, Cuomo V, Trapani G.
    Int J Pharm; 2011 Oct 31; 419(1-2):296-307. PubMed ID: 21821107
    [Abstract] [Full Text] [Related]

  • 13. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
    Shah B, Khunt D, Misra M, Padh H.
    Int J Biol Macromol; 2016 Aug 31; 89():206-18. PubMed ID: 27130654
    [Abstract] [Full Text] [Related]

  • 14. Novel surface modified solid lipid nanoparticles as intranasal carriers for ropinirole hydrochloride: application of factorial design approach.
    Pardeshi CV, Rajput PV, Belgamwar VS, Tekade AR, Surana SJ.
    Drug Deliv; 2013 Aug 31; 20(1):47-56. PubMed ID: 23311653
    [Abstract] [Full Text] [Related]

  • 15. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
    Mittal D, Md S, Hasan Q, Fazil M, Ali A, Baboota S, Ali J.
    Drug Deliv; 2016 Aug 31; 23(1):130-9. PubMed ID: 24786489
    [Abstract] [Full Text] [Related]

  • 16. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
    Patel S, Chavhan S, Soni H, Babbar AK, Mathur R, Mishra AK, Sawant K.
    J Drug Target; 2011 Jul 31; 19(6):468-74. PubMed ID: 20958095
    [Abstract] [Full Text] [Related]

  • 17. PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment.
    Karavasili C, Bouropoulos N, Sygellou L, Amanatiadou EP, Vizirianakis IS, Fatouros DG.
    Mater Sci Eng C Mater Biol Appl; 2016 Feb 31; 59():1053-1062. PubMed ID: 26652464
    [Abstract] [Full Text] [Related]

  • 18. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
    Brar V, Kaur G.
    Pharm Nanotechnol; 2018 Feb 31; 6(3):180-191. PubMed ID: 30101724
    [Abstract] [Full Text] [Related]

  • 19. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R, Yallamalli IM, Yalavarthi PR.
    Drug Dev Ind Pharm; 2019 Aug 31; 45(8):1342-1350. PubMed ID: 31094571
    [Abstract] [Full Text] [Related]

  • 20. Spray-dried alginate microparticles for potential intranasal delivery of ropinirole hydrochloride: development, characterization and histopathological evaluation.
    Hussein N, Omer H, Ismael A, Albed Alhnan M, Elhissi A, Ahmed W.
    Pharm Dev Technol; 2020 Mar 31; 25(3):290-299. PubMed ID: 30626225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.